The effects of cervical spinal cord stimulation on the cerebral blood flow.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON26631

Enrollment

Registered

2012-05-17

Start date

2012-07-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

SCS, cerebral blood flow, autoregulation

Interventions

The frequency and amplitude of the SCS device will be changed. The pulse-width will not be changed. The frequency will be of 130 Hz, pulse-width between 100 Hz- 130 Hz. The voltage of the stimulation

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with SCS, stimulating the cervical myelum; 2. Age > 18 years; 3. Informed consent signed by patient.

Exclusion criteria

Exclusion criteria: 1. The presence of any other implanted electronic device (including pacemakers); 2. Pre-existing disease that can obscure follow-up or experimental set- up such as amputations; 3. Insufficient temporal bony windows; 4. The use of sympathicomimetic or sympathicolytic agents.

Design outcomes

Primary

Measure	Time frame
Cerebral blood flow velocities as measured with TCD combined with cerebral oxygenation determined by NIRS.	—

Secondary

Measure	Time frame
1. Body surface temperature measured by thermography; 2. Blood pressure; 3. Heart rate; 4. End tidal CO2; 5. Registration of adverse events.	—

Contacts

Public ContactL.P. Govindarajan

Oude Ebbingestraat 57a

lpgovindarajan@gmail.com+31 (0)6 12218784

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)